91 related articles for article (PubMed ID: 23196026)
1. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities.
Laakmann G; Dienel A; Kieser M
Phytomedicine; 1998 Dec; 5(6):435-42. PubMed ID: 23196026
[TBL] [Abstract][Full Text] [Related]
2. St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy.
Laakmann G; Schüle C; Baghai T; Kieser M
Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():54-9. PubMed ID: 9684948
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
Kalb R; Trautmann-Sponsel RD; Kieser M
Pharmacopsychiatry; 2001 May; 34(3):96-103. PubMed ID: 11434406
[TBL] [Abstract][Full Text] [Related]
4. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
Kasper S; Volz HP; Möller HJ; Dienel A; Kieser M
Eur Neuropsychopharmacol; 2008 Nov; 18(11):803-13. PubMed ID: 18694635
[TBL] [Abstract][Full Text] [Related]
5. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials.
Kasper S; Dienel A
Psychopharmacology (Berl); 2002 Nov; 164(3):301-8. PubMed ID: 12424554
[TBL] [Abstract][Full Text] [Related]
6. Superior efficacy of St John's wort extract WS 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298].
Kasper S; Anghelescu IG; Szegedi A; Dienel A; Kieser M
BMC Med; 2006 Jun; 4():14. PubMed ID: 16796730
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
Anghelescu IG; Kohnen R; Szegedi A; Klement S; Kieser M
Pharmacopsychiatry; 2006 Nov; 39(6):213-9. PubMed ID: 17124643
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
Lecrubier Y; Clerc G; Didi R; Kieser M
Am J Psychiatry; 2002 Aug; 159(8):1361-6. PubMed ID: 12153829
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
Randløv C; Mehlsen J; Thomsen CF; Hedman C; von Fircks H; Winther K
Phytomedicine; 2006 Mar; 13(4):215-21. PubMed ID: 16423519
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of St. John's wort extract WS 5570 in acute treatment of mild depression: a reanalysis of data from controlled clinical trials.
Kasper S; Gastpar M; Müller WE; Volz HP; Dienel A; Kieser M; Möller HJ
Eur Arch Psychiatry Clin Neurosci; 2008 Feb; 258(1):59-63. PubMed ID: 18084790
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs.
Schulz V
Phytomedicine; 2002 Jul; 9(5):468-74. PubMed ID: 12222670
[TBL] [Abstract][Full Text] [Related]
12. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin.
Mueller SC; Uehleke B; Woehling H; Petzsch M; Majcher-Peszynska J; Hehl EM; Sievers H; Frank B; Riethling AK; Drewelow B
Clin Pharmacol Ther; 2004 Jun; 75(6):546-57. PubMed ID: 15179409
[TBL] [Abstract][Full Text] [Related]
13. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
[TBL] [Abstract][Full Text] [Related]
14. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572.
Kieser M; Szegedi A
Pharmacopsychiatry; 2005 Sep; 38(5):194-200. PubMed ID: 16189745
[TBL] [Abstract][Full Text] [Related]
15. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
Fava M; Alpert J; Nierenberg AA; Mischoulon D; Otto MW; Zajecka J; Murck H; Rosenbaum JF
J Clin Psychopharmacol; 2005 Oct; 25(5):441-7. PubMed ID: 16160619
[TBL] [Abstract][Full Text] [Related]
16. [Use of St. John's Wort for depression in primary care - a non-interventional study].
Musselmann B; Rychlik R; Burkart M
MMW Fortschr Med; 2011 Dec; 153 Suppl 4():119-27. PubMed ID: 23964473
[TBL] [Abstract][Full Text] [Related]
17. Duration of response after treatment of mild to moderate depression with Hypericum extract STW 3-VI, citalopram and placebo: a reanalysis of data from a controlled clinical trial.
Singer A; Schmidt M; Hauke W; Stade K
Phytomedicine; 2011 Jun; 18(8-9):739-42. PubMed ID: 21514125
[TBL] [Abstract][Full Text] [Related]
18. Treatment of anxiety, tension and restlessness states with Kava special extract WS 1490 in general practice: a randomized placebo-controlled double-blind multicenter trial.
Gastpar M; Klimm HD
Phytomedicine; 2003 Nov; 10(8):631-9. PubMed ID: 14692723
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10.
Vorbach EU; Arnoldt KH; Hübner WD
Pharmacopsychiatry; 1997 Sep; 30 Suppl 2():81-5. PubMed ID: 9342765
[TBL] [Abstract][Full Text] [Related]
20. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
Volz HP; Murck H; Kasper S; Möller HJ
Psychopharmacology (Berl); 2002 Nov; 164(3):294-300. PubMed ID: 12424553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]